Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Search Results 1-10 of 10 for Prednisone
Another strategy for preventing GN recurrence involves long-term prednisone treatment.
"For example, it is important to taper systemic prednisone to a daily dose of 10 mg or less within three months, because of the potential for side effects," says Dr.
Glucocorticoids: Prednisone and other steroids have been shown to have beneficial effects on ALP and liver histology in the early stages of PBC.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: A multicentre, randomised, open-label, phase 2, crossover trial.
"All patients also received maintenance immunosuppression that included a CNI , an anti-metabolite (azathioprine or mycophenolate mofetil) and tapering doses of prednisone.
The findings, which were pre-published online in Blood First Edition, are significant because patients with ALK-positive tumors respond well to standard chemotherapy (typically cyclophosphamide, doxorubicin, vincristine and prednisone...
Reversibility is maintained with oral immunosuppressants such as prednisone, azathioprine, mycophenolate, methotrexate or rituximab — at the minimum effective dosage, to minimize side effects.
The recently completed randomized, placebo-controlled, phase III trial of mepolizumab (300 mg subcutaneously once a month) has shown superiority to the standard of care for all primary and secondary endpoints of the trial, leading to FDA approval of ...
Other risk factors for pediatric AP include gallstones, undetermined viruses and reactions to certain drugs, especially valproic acid, L-asparaginase, prednisone and 6-mercaptopurine, although no clear mechanism has been identified f...
The steroid-sparing agent is typically continued for at least six to 12 months after prednisone has been discontinued.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.